Younossi, Z. Et Al. 2025. Metabolic dysfunction-and alcohol-associated steatotic liver disease is associated with higher risk of advanced fibrosis and mortality than metabolic dysfunction-associated steatotic liver disease: data from a large global biopsy-proven cohort. JOURNAL OF HEPATOLOGY .

Younossi, Z., de Avila, L., Petta, S., Nakajima, A., Crespo, J., Kim, S. U., ... Castera, L.(2025). Metabolic dysfunction-and alcohol-associated steatotic liver disease is associated with higher risk of advanced fibrosis and mortality than metabolic dysfunction-associated steatotic liver disease: data from a large global biopsy-proven cohort. JOURNAL OF HEPATOLOGY .

Younossi, Zobair Et Al. "Metabolic dysfunction-and alcohol-associated steatotic liver disease is associated with higher risk of advanced fibrosis and mortality than metabolic dysfunction-associated steatotic liver disease: data from a large global biopsy-proven cohort," JOURNAL OF HEPATOLOGY , 2025

Younossi, Zobair Et Al. "Metabolic dysfunction-and alcohol-associated steatotic liver disease is associated with higher risk of advanced fibrosis and mortality than metabolic dysfunction-associated steatotic liver disease: data from a large global biopsy-proven cohort." JOURNAL OF HEPATOLOGY , 2025

Younossi, Z. Et Al. (2025) . "Metabolic dysfunction-and alcohol-associated steatotic liver disease is associated with higher risk of advanced fibrosis and mortality than metabolic dysfunction-associated steatotic liver disease: data from a large global biopsy-proven cohort." JOURNAL OF HEPATOLOGY .

@article{article, author={Zobair Younossi Et Al. }, title={Metabolic dysfunction-and alcohol-associated steatotic liver disease is associated with higher risk of advanced fibrosis and mortality than metabolic dysfunction-associated steatotic liver disease: data from a large global biopsy-proven cohort}, journal={JOURNAL OF HEPATOLOGY}, year=2025}